CollPlant Biotechnologies Ltd (CLGN) Gross margin 2018–2025
CollPlant Biotechnologies Ltd (CLGN) gross margin by fiscal year — reported gross profit divided by reported revenue.
64.8%FY2025 · since FY2018: 66.9% → 64.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 64.8% | +280.3 pp |
| FY2024 | -215.5% | -297.4 pp |
| FY2023 | 81.8% | +115.6 pp |
| FY2022 | -33.8% | -121.0 pp |
| FY2021 | 87.2% | +36.1 pp |
| FY2020 | 51.1% | +32.1 pp |
| FY2019 | 18.9% | -48.0 pp |
| FY2018 | 66.9% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLGN financial trends
CLGN RevenueCLGN Net incomeCLGN Net marginCLGN Gross profitCLGN Operating incomeCLGN Operating marginCLGN Operating cash flowCLGN Free cash flowCLGN Capital expendituresCLGN Return on equityCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Total liabilitiesCLGN Shareholders’ equityCLGN overview →